Lamivudine plus zidovudine compared with zalcitabine plus zidovudine in patients with HIV infection. A randomized, double-blind, placebo-controlled trial. North American HIV Working Party. | Ann Intern Med;125(3): 161-72, 1996 Aug 01. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Lamivudine plus zidovudine compared with zalcitabine plus zidovudine in patients with HIV infection. A randomized, double-blind, placebo-controlled trial. North American HIV Working Party.

Bartlett, J A; Benoit, S L; Johnson, V A; Quinn, J B; Sepulveda, G E; Ehmann, W C; Tsoukas, C; Fallon, M A; Self, P L; Rubin, M.

Affiliation

Bartlett JA; Duke University Medical Center, Durham, North Carolina, USA.

Ann Intern Med ; 125(3): 161-72, 1996 Aug 01.

Article in En | MEDLINE | ID: mdl-8686973

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Zidovudine / HIV Infections / Zalcitabine Type of study: Clinical_trials Limits: Adult / Female / Humans / Male Language: En Journal: Ann Intern Med Year: 1996 Document type: Article Affiliation country: Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Zidovudine / HIV Infections / Zalcitabine Type of study: Clinical_trials Limits: Adult / Female / Humans / Male Language: En Journal: Ann Intern Med Year: 1996 Document type: Article Affiliation country: Country of publication: